Payden & Rygel Investment Group Abbott Laboratories Transaction History

Payden & Rygel Investment Group

  • $1.24 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 08, 2024
BUY
$109.52 - $120.96 $2.29 Million - $2.53 Million
20,910 Added 18.57%
133,500 $15.2 Million
Q1 2024

May 13, 2024
BUY
$109.52 - $120.96 $2.29 Million - $2.53 Million
20,910 Added 18.57%
133,500 $15.2 Million
Q3 2023

Oct 08, 2024
BUY
$95.53 - $114.62 $10.8 Million - $12.9 Million
112,590 New
112,590 $10.9 Million
Q3 2023

Nov 08, 2023
BUY
$95.53 - $114.62 $10.8 Million - $12.9 Million
112,590 New
112,590 $10.9 Million

Others Institutions Holding ABT

# of Institutions
3,290
Shares Held
1.34B
Call Options Held
9.72M
Put Options Held
8.45M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Payden & Rygel Investment Group Portfolio

Follow Payden & Rygel Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel Investment Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email